Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
P. Kremsner, R. A. Ahuad Guerrero, E. Arana-Arri, G. Aroca-Martínez +173 more
2021Lancet. Infectious Diseases (Print)129 citations Open access
Semantic Scholar

